Home/Filings/4/0001209191-23-041404
4//SEC Filing

LOBERG MICHAEL D 4

Accession 0001209191-23-041404

CIK 0001496323other

Filed

Jul 4, 8:00 PM ET

Accepted

Jul 5, 9:13 PM ET

Size

7.3 KB

Accession

0001209191-23-041404

Insider Transaction Report

Form 4
Period: 2023-06-30
Transactions
  • Award

    Common Stock

    2023-06-30+1,1381,138 total
Holdings
  • Common Stock

    (indirect: See footnote)
    33,807
  • Common Stock

    (indirect: See footnote)
    46,845
Footnotes (4)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The amount reflects payment of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy.
  • [F2]The number of shares held reflects the transfer on April 17, 2023 of 1,138 shares from the Reporting Person to Revocable Deed of Trust of Michael D. Loberg (Michael and Melinda Loberg, Trustees) (the "Revocable Deed of Trust").
  • [F3]The shares are held by the Revocable Deed of Trust. The number of shares held reflects (i) the transfer on April 6, 2023 of 9,336 shares from Michael D. Loberg Qualified Annuity Interest Trust IX (Michael and Melinda Loberg, Trustees) ("Trust IX") to the Revocable Deed of Trust and (ii) the transfer on April 17, 2023 of 1,138 shares from the Reporting Person to the Revocable Deed of Trust.
  • [F4]The shares are held by Trust IX. The number of shares held reflects the transfer on April 6, 2023 of 9,336 shares from Trust IX to the Revocable Deed of Trust.

Issuer

IGM Biosciences, Inc.

CIK 0001496323

Entity typeother

Related Parties

1
  • filerCIK 0001233414

Filing Metadata

Form type
4
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 9:13 PM ET
Size
7.3 KB